Results Snapshot
Figures in Cr
Consolidated - Profit And Loss Results
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
No of Months
12
12
12
12
12
12
Operating Income
29,001.00
24,855.00
23,455.00
24,774.00
23,098.00
19,563.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
29,001.00
24,855.00
23,455.00
24,774.00
23,098.00
19,563.00
Expenditure (Ex Depriciation)
Stock Adjustments
-946.00
-409.00
816.00
-730.00
-101.00
-675.00
Raw Materials Consumed
13,549.00
11,702.00
9,323.00
10,632.00
9,837.00
9,388.00
Power & Fuel Cost
826.00
842.00
626.00
589.00
587.00
556.00
Employee Cost
3,922.00
3,522.00
3,450.00
3,535.00
3,219.00
2,584.00
Operating Expenses
1,142.00
1,026.00
1,058.00
1,109.00
964.00
953.00
General and Administration Expenses
-1.00
-1.00
-1.00
-1.00
-1.00
-1.00
Selling and Distribution Expenses
1,684.00
1,685.00
1,496.00
1,564.00
1,524.00
1,125.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
691.00
746.00
459.00
666.00
565.00
439.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
23,158.00
21,136.00
19,068.00
19,441.00
18,234.00
15,611.00
Operating Profit (PBDIT) excl Other Income
5,843.00
3,718.00
4,386.00
5,333.00
4,864.00
3,951.00
Other Income
557.00
290.00
320.00
380.00
191.00
155.00
Operating Profit (PBDIT)
6,400.00
4,009.00
4,707.00
5,714.00
5,056.00
4,107.00
Interest
289.00
140.00
48.00
74.00
305.00
262.00
Profit before Depriciation and Tax
6,110.00
3,868.00
4,658.00
5,639.00
4,751.00
3,844.00
Depreciation
1,521.00
1,244.00
1,126.00
1,055.00
966.00
667.00
Profit Before Taxation & Exceptional Items
4,589.00
2,624.00
3,531.00
4,584.00
3,784.00
3,176.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
4,379.00
2,612.00
3,372.00
7,343.00
3,743.00
3,091.00
Provision for Tax
1,211.00
684.00
725.00
2,009.00
899.00
726.00
Profit After Tax
3,186.00
1,939.00
2,678.00
5,389.00
2,858.00
2,361.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
23,910.00
22,518.00
20,136.00
15,042.00
12,398.00
10,211.00
Profit Available for appropriations
27,083.00
24,446.00
22,784.00
20,377.00
15,243.00
12,576.00
Appropriations
27,083.00
24,446.00
22,784.00
20,377.00
15,243.00
12,576.00
Equity Dividend (%)
450.00%
750.00%
900.00%
400.00%
300.00%
250.00%
Earnings Per Share
54.16
32.90
45.20
91.05
48.56
40.36
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2025 is 2.70% vs -16.78% in Mar 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2025 is 15.00% vs 28.49% in Mar 2024
Interest
YoY Growth in year ended Mar 2025 is 25.98% vs 58.81% in Mar 2024
Profit After Tax
YoY Growth in year ended Mar 2025 is -8.07% vs 54.43% in Mar 2024
Compare Profit and Loss Results of Aurobindo Pharma
Figures in Cr
consolidated - Profit And Loss Results
Change(INR)
Change(%)
No of Months
12
12
Operating Income
29,001.00
12,207.00
16,794.00
137.58%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
29,001.00
12,207.00
16,794.00
137.58%
Expenditure (Ex Depriciation)
Stock Adjustments
-946.00
-183.00
-763.00
-416.94%
Raw Materials Consumed
13,549.00
3,672.00
9,877.00
268.98%
Power & Fuel Cost
826.00
149.00
677.00
454.36%
Employee Cost
3,922.00
2,692.00
1,230.00
45.69%
Operating Expenses
1,142.00
246.00
896.00
364.23%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
1,684.00
1,164.00
520.00
44.67%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
691.00
161.00
530.00
329.19%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
23,158.00
9,186.00
13,972.00
152.10%
Operating Profit (PBDIT) excl Other Income
5,843.00
3,020.00
2,823.00
93.48%
Other Income
557.00
536.00
21.00
3.92%
Operating Profit (PBDIT)
6,400.00
3,557.00
2,843.00
79.93%
Interest
289.00
431.00
-142.00
-32.95%
Profit before Depriciation and Tax
6,110.00
3,125.00
2,985.00
95.52%
Depreciation
1,521.00
621.00
900.00
144.93%
Profit Before Taxation & Exceptional Items
4,589.00
2,504.00
2,085.00
83.27%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
4,379.00
2,516.00
1,863.00
74.05%
Provision for Tax
1,211.00
509.00
702.00
137.92%
Profit After Tax
3,186.00
1,994.00
1,192.00
59.78%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
23,910.00
9,918.00
13,992.00
141.08%
Profit Available for appropriations
27,083.00
11,905.00
15,178.00
127.49%
Appropriations
27,083.00
11,905.00
15,178.00
127.49%
Equity Dividend (%)
450%
0%
450.00
Earnings Per Share
54.16
49.28
4.88
9.90%
Profit And Loss - Net Sales
Net Sales 10,933.30 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 2.70% vs -16.78% in Mar 2024
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 2,557.57 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 15.00% vs 28.49% in Mar 2024
Profit And Loss - Interest
Interest 230.04 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 25.98% vs 58.81% in Mar 2024
Profit And Loss - Profit After Tax
Profit After Tax 1,746.79 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -8.07% vs 54.43% in Mar 2024






